professional development training for CHWs on dental health (GRIN) for Dental Health

Phase-Based Progress Estimates
KDH Research & Communication, Atlanta, GA
Dental Health
professional development training for CHWs on dental health (GRIN) - Other
All Sexes
What conditions do you have?

Study Summary

Two arm study, experimental and control, to explore the impact of an online training program to help community health workers conduct effective outreach to support the dental health of African American youth via their caregivers.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Two weeks after study completion

Two weeks after study completion
Knowledge, attitudes, self-efficacy and intentions

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
exposed to GRIN training
1 of 2
Active Control
Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: professional development training for CHWs on dental health (GRIN) · No Placebo Group · N/A

exposed to GRIN training
Experimental Group · 1 Intervention: professional development training for CHWs on dental health (GRIN) · Intervention Types: Other
control/unexposedNoIntervention Group · 1 Intervention: control/unexposed · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: two weeks after study completion
Closest Location: KDH Research & Communication · Atlanta, GA
Photo of Atlanta 1Photo of Atlanta 2Photo of Atlanta 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Dental Health
0 CompletedClinical Trials

Who is running the clinical trial?

KDH Research & CommunicationLead Sponsor

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.